Viromed Medical AG / DE000A3MQR65
26.11.2025 - 17:02:53Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care
| EQS-Ad-hoc: Viromed Medical AG / Key word(s): Alliance/Miscellaneous 26-Nov-2025 / 17:02 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. AD HOC ANNOUNCEMENT Pinneberg, November 26, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), confirms market rumors that the company is in advanced talks with a global MedTech company in the field of wound treatment about signing a cooperation agreement. This mainly involves the use of the cold plasma medical device ViroCAP®/OEM to support wound healing. Viromed will inform shareholders of further developments in an appropriate manner and in accordance with the legal obligations. Notifying person: Uwe Perbandt, CEO Viromed Medical AG Contact Viromed: E-Mail: kontakt@viromed-medical.de End of Inside Information 26-Nov-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |
| Language: | English |
| Company: | Viromed Medical AG |
| Hauptstraße 105 | |
| 25462 Rellingen | |
| Germany | |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A3MQR65 |
| WKN: | A3MQR6 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Hamburg, Tradegate Exchange |
| EQS News ID: | 2236382 |
| End of Announcement | EQS News Service |
| |
2236382 26-Nov-2025 CET/CEST
